Follow the BioPorto A/S share price and the full directors' dealings record of the company, a publicly traded company based in Denmark. Shares are quoted on the DK market, under the authority of Finanstilsynet DK. Operating in the Health Care sector, BioPorto A/S has recorded 40 reports. Market capitalisation: €596.6m. The latest transaction was reported on 24 November 2025 (Subscription). All data is accessible without an account.
40
Insider Decl.
n/a
Thresholds
€46m
12 ops.
Buy Volume
€6m
2 ops.
Sell Volume
Analyst consensus: bullish or bearish?
Analysts rate BioPorto A/S Strong Buy (bullish), based on 1 analysts. Average price target: DKK 1.75.
41Σ signal
Buys €46m€6m Sells
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental score
Ranked 23,811 of 29,062 companies
29.3
score / 100
Value
14
Quality
45
FCF yld-13%
Earn yld-14%
EV/EBITDA·
ROE-126%
Gross mgn75%
Net mgn·
Debt/EBITDA·
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Σ
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
BioPorto A/S es una empresa danesa especializada en el desarrollo de diagnósticos médicos. Se centra en pruebas innovadoras para enfermedades graves, particularmente trastornos renales.